Suven Life Sciences has informed that a meeting of the board of directors of the company will be held on August 14, 2012, to consider and approve the audited annual accounts for the year ended March 31, 2012 and to recommend dividend for the financial year ended March 31,2012, if any.
Further, the board will announce book closure for the purpose of AGM and will consider and take on record the un-audited financial results for the first quarter ended June 30, 2012.
The above information is a part of company's filings submitted to BSE.
